Apolipoprotein C-III in patients with systemic lupus erythematosus

Abstract Background Systemic lupus erythematosus (SLE) has been associated with atherosclerotic cardiovascular disease (CV) and an altered lipid profile. High levels of apolipoprotein C-III (ApoC3) are associated with elevated triglyceride levels and an increased risk of CV. In the present study, we...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Candelaria Martín-González, Carmen Ferrer-Moure, Juan Carlos Quevedo-Abeledo, Antonia de Vera-González, Alejandra González-Delgado, Julio Sánchez-Martín, Miguel Á. González-Gay, Iván Ferraz-Amaro
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2022-05-01
Edice:Arthritis Research & Therapy
Témata:
Systemic lupus erythematosus
Apolipoprotein C3
On-line přístup:https://doi.org/10.1186/s13075-022-02793-y
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky